Habitual dietary intake of β-carotene, vitamin C, folate, or vitamin E may interact with single nucleotide polymorphisms on brachial–ankle pulse wave velocity in healthy adults

European Journal of Nutrition

Volumn 55, Issue 2, 2016, Pages 855-866

  Park, Clara Yongjoo ^a   Jung, Sukyoung ^a   Kim, Mi Kyung ^a   Choi, Bo Youl ^a   Shin, Min Ho ^b   Shin, Dong Hoon ^c   Lee, Young Hoon ^d   Chun, Byung Yeol ^e   Hong, Kyung Won ^f   Hwang, Joo Yeon ^f  

^a Hanyang University   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c Keimyung University   (South Korea)

^d Wonkwang University   (South Korea)

^e Kyungpook National University School of Medicine   (South Korea)

^f Korea National Institute of Health   (South Korea)

Author keywords

Arterial stiffness; Cross sectional study; Gene nutrient interaction; Pulse wave velocity; Vitamin intake

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; FOLIC ACID;

ARTERIAL STIFFNESS; ARTICLE; BODY MASS; BRACHIAL ANKLE PULSE WAVE VELOCITY; CARBOHYDRATE INTAKE; DIETARY INTAKE; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HOMOZYGOTE; HUMAN; KOREAN (PEOPLE); MALE; NORMAL HUMAN; PORTION SIZE; PROTEIN INTAKE; PULSE WAVE; RURAL AREA; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN INTAKE; ALLELE; ANKLE BRACHIAL INDEX; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIET; DRUG EFFECTS; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; MIDDLE AGED; MULTICENTER STUDY; NUTRITIONAL ASSESSMENT; RISK FACTOR; RURAL POPULATION; SOUTH KOREA;

ALLELES; ANKLE BRACHIAL INDEX; ASCORBIC ACID; BETA CAROTENE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIET; FEMALE; FOLIC ACID; GENE-ENVIRONMENT INTERACTION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NUTRITION ASSESSMENT; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA; RISK FACTORS; RURAL POPULATION; VASCULAR STIFFNESS; VITAMIN E;

EID: 84959192152     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-015-0896-z     Document Type: Article

References (65)

1. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML et al (2006) Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 113(5):657–663. doi:10.1161/CIRCULATIONAHA.105.555235
2. World Health Organization (2011) Global status report on noncommunicable diseases 2010. World Health Organization, Geneva
3. Murphy SL, Xu JQ, Kochanek KD (2010) Deaths: final data for 2010. National vital statistics reports, vol 61. National Center for Health Statistics, Hyattsville
4. Statistics Korea (2013) Cause of death in 2012, vol 2014. Statistics Korea, Daejeon
5. Willett WC, Koplan JP, Nugent R, Dusenbury C, Puska P, Gaziano TA (2006) Chapter 44 prevention of chronic disease by means of diet and lifestyle changes. In: Jamison DT BJ, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P (ed) Disease control priorities in developing countries, 2nd edn. World Bank, Washington, DC
6. Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ et al (2009) Genome-wide association study of blood pressure and hypertension. Nat Genet 41(6):677–687
7. Levy D, Larson M, Benjamin E, Newton-Cheh C, Wang T, Hwang S-J, Vasan R, Mitchell G (2007) Framingham Heart Study 100K project: genome-wide associations for blood pressure and arterial stiffness. BMC Med Genet 8(Suppl. 1):S3. doi:10.1186/1471-2350-8-S1-S3
8. Bazzano LA, He J, Ogden LG, Loria CM, Vupputuri S, Myers L, Whelton PK (2002) Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Am J Clin Nutr 76(1):93–99
9. Kim OY, Yoe HY, Kim HJ, Park JY, Kim JY et al (2010) Independent inverse relationship between serum lycopene concentration and arterial stiffness. Atherosclerosis 208(2):581–586
10. Plantinga Y, Ghiadoni L, Magagna A, Giannarelli C, Franzoni F, Taddei S, Salvetti A (2007) Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens 20(4):392–397. doi:10.1016/j.amjhyper.2006.09.021
11. Mullan BA, Young IS, Fee H, McCance DR (2002) Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension 40(6):804–809
12. Shargorodsky M, Debby O, Matas Z, Zimlichman R (2010) Effect of long-term treatment with antioxidants (vitamin C, vitamin E, coenzyme Q10 and selenium) on arterial compliance, humoral factors and inflammatory markers in patients with multiple cardiovascular risk factors. Nutr Metab (Lond) 7:55. doi:10.1186/1743-7075-7-55
13. Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, Manson JE (2008) Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease. JAMA 299(17):2027–2036. doi:10.1001/jama.299.17.2027
14. Zureik M, Galan P, Bertrais S, Mennen L, Czernichow S, Blacher J, Ducimetiere P, Hercberg S (2004) Effects of long-term daily low-dose supplementation with antioxidant vitamins and minerals on structure and function of large arteries. Arterioscler Thromb Vasc Biol 24(8):1485–1491. doi:10.1161/01.ATV.0000136648.62973.c8
15. Wilkinson IB, Megson IL, MacCallum H, Sogo N, Cockcroft JR, Webb DJ (1999) Oral vitamin C reduces arterial stiffness and platelet aggregation in humans. J Cardiovasc Pharmacol 34(5):690–693
16. Williams C, Kingwell BA, Burke K, McPherson J, Dart AM (2005) Folic acid supplementation for 3 wk reduces pulse pressure and large artery stiffness independent of MTHFR genotype. Am J Clin Nutr 82(1):26–31
17. Khandanpour N, Armon MP, Jennings B, Finglas PM, Willis G, Clark A, Meyer FJ (2009) Randomized clinical trial of folate supplementation in patients with peripheral arterial disease. Br J Surg 96(9):990–998. doi:10.1002/bjs.6670
18. Doshi SN, McDowell IF, Moat SJ, Payne N, Durrant HJ, Lewis MJ, Goodfellow J (2002) Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 105(1):22–26
19. Bleys J, Miller ER, Pastor-Barriuso R, Appel LJ, Guallar E (2006) Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am J Clin Nutr 84(4):880–887
20. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ (2003) Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361(9374):2017–2023
21. Kim K, Yang YJ, Kim MK (2012) Interactions of single nucleotide polymorphisms with dietary calcium intake on the risk of metabolic syndrome. Am J Clin Nutr 95(1):231–240. doi:10.3945/ajcn.111.022749
22. Ordovas JM, Lopez-Miranda J, Mata P, Perez-Jimenez F, Lichtenstein AH, Schaefer EJ (1995) Gene–diet interaction in determining plasma lipid response to dietary intervention. Atherosclerosis 118:S11–S27
23. Martinez JA, Corbalan MS, Sanchez-Villegas A, Forga L, Marti A, Martinez-Gonzalez MA (2003) Obesity risk is associated with carbohydrate intake in women carrying the Gln27Glu beta2-adrenoceptor polymorphism. J Nutr 133(8):2549–2554
24. Lai C-Q, Parnell LD, Troen AM, Shen J, Caouette H et al (2010) MAT1A variants are associated with hypertension, stroke, and markers of DNA damage and are modulated by plasma vitamin B-6 and folate. Am J Clin Nutr 91(5):1377–1386
25. Tanaka H, Munakata M, Kawano Y, Ohishi M, Shoji T et al (2009) Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens 27(10):2022
26. Ahn Y, Kwon E, Shim JE, Park MK, Joo Y, Kimm K, Park C, Kim DH (2007) Validation and reproducibility of food frequency questionnaire for Korean genome epidemiologic study. Eur J Clin Nutr 61(12):1435–1441. doi:10.1038/sj.ejcn.1602657
27. The Korean Nutrition Society (ed) (2000) Food Composition table. In: Recommended dietary allowances for Koreans, 7th edn. The Korean Nutrition Society, Seoul
28. Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH et al (2009) A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet 41(5):527–534. doi:10.1038/ng.357
29. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, Koji Y, Hori S, Yamamoto Y (2002) Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 25(3):359–364
30. Hsu L, Jiao S, Dai JY, Hutter C, Peters U, Kooperberg C (2012) Powerful cocktail methods for detecting genome-wide gene–environment interaction. Genet Epidemiol 36(3):183–194. doi:10.1002/gepi.21610
31. Kooperberg C, Leblanc M (2008) Increasing the power of identifying gene × gene interactions in genome-wide association studies. Genet Epidemiol 32(3):255–263. doi:10.1002/gepi.20300
32. Lacolley P, Challande P, Osborne-Pellegrin M, Regnault V (2009) Genetics and pathophysiology of arterial stiffness. Cardiovasc Res 81(4):637–648. doi:10.1093/cvr/cvn353
33. O’Donnell CJ, Cupples LA, D’Agostino RB, Fox CS, Hoffmann U et al (2007) Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI’s Framingham Heart Study. BMC Med Genet 8(Suppl. 1):S4. doi:10.1186/1471-2350-8-S1-S4
34. Tarasov KV, Sanna S, Scuteri A, Strait JB, Orru M et al (2009) COL4A1 is associated with arterial stiffness by genome-wide association scan. Circ Cardiovasc Genet 2(2):151–158. doi:10.1161/CIRCGENETICS.108.823245
35. Nakamura M, Sugiura M, Aoki N (2006) High beta-carotene and beta-cryptoxanthin are associated with low pulse wave velocity. Atherosclerosis 184(2):363–369. doi:10.1016/j.atherosclerosis.2005.04.006
36. Burri BJ, Neidlinger TR, Clifford AJ (2001) Serum carotenoid depletion follows first-order kinetics in healthy adult women fed naturally low carotenoid diets. J Nutr 131(8):2096–2100
37. Darblade B, Pendaries C, Krust A, Dupont S, Fouque MJ, Rami J, Chambon P, Bayard F, Arnal JF (2002) Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor. Circ Res 90(4):413–419
38. Brouchet L, Krust A, Dupont S, Chambon P, Bayard F, Arnal JF (2001) Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta. Circulation 103(3):423–428
39. Pare G, Krust A, Karas RH, Dupont S, Aronovitz M, Chambon P, Mendelsohn ME (2002) Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ Res 90(10):1087–1092
40. Kjaergaard AD, Ellervik C, Tybjaerg-Hansen A, Axelsson CK, Gronholdt ML, Grande P, Jensen GB, Nordestgaard BG (2007) Estrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case–control studies and a meta-analysis. Circulation 115(7):861–871. doi:10.1161/circulationaha.106.615567
41. Shearman AM, Cupples LA, Demissie S, Peter I, Schmid CH, Karas RH, Mendelsohn ME, Housman DE, Levy D (2003) Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA 290(17):2263–2270. doi:10.1001/jama.290.17.2263
42. Kunnas T, Silander K, Karvanen J, Valkeapaa M, Salomaa V, Nikkari S (2010) ESR1 genetic variants, haplotypes and the risk of coronary heart disease and ischemic stroke in the Finnish population: a prospective follow-up study. Atherosclerosis 211(1):200–202. doi:10.1016/j.atherosclerosis.2010.01.026
43. Schuit SC, Oei HH, Witteman JC, Geurts van Kessel CH, van Meurs JB et al (2004) Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction. JAMA 291(24):2969–2977. doi:10.1001/jama.291.24.2969
44. Kundu A, Anand A (2013) Computational study of ADD1 gene polymorphism associated with hypertension. Cell Biochem Biophys 65(1):13–19
45. Watanabe Y, Metoki H, Ohkubo T, Katsuya T, Tabara Y et al (2010) Accumulation of common polymorphisms is associated with development of hypertension: a 12-year follow-up from the Ohasama study. Hypertens Res 33(2):129–134. doi:10.1038/hr.2009.193
46. Niu WQ, Zhang Y, Ji KD, Gao PJ, Zhu DL (2010) Lack of association between alpha-adducin G460W polymorphism and hypertension: evidence from a case-control study and a meta-analysis. J Hum Hypertens 24(7):467–474. doi:10.1038/jhh.2009.88
47. Wang R, Zhong B, Liu Y, Wang C (2010) Association between a-adducin gene polymorphism (Gly460Trp) and genetic predisposition to salt sensitivity: a meta-analysis. J Appl Genet 51(1):87–94
48. Efendiev R, Krmar RT, Ogimoto G, Zwiller J, Tripodi G, Katz AI, Bianchi G, Pedemonte CH, Bertorello AM (2004) Hypertension-linked mutation in the adducin alpha-subunit leads to higher AP2-mu2 phosphorylation and impaired Na+, K+-ATPase trafficking in response to GPCR signals and intracellular sodium. Circ Res 95(11):1100–1108. doi:10.1161/01.RES.0000149570.20845.89
49. Bianchi G (2005) Genetic variations of tubular sodium reabsorption leading to “primary” hypertension: from gene polymorphism to clinical symptoms. Am J Physiol Regul Integr Comp Physiol 289(6):R1536–R1549. doi:10.1152/ajpregu.00441.2005
50. Kumar R, Kohli S, Alam P, Barkotoky R, Gupta M, Tyagi S, Jain SK, Pasha MAQ (2013) Interactions between the FTO and GNB3 genes contribute to varied clinical phenotypes in hypertension. PLoS One 8(5). doi:10.1371/journal.pone.0063934
51. Siffert W (2000) G protein β3 subunit 825T allele, hypertension, obesity, and diabetic nephropathy. Nephrol Dial Transplant 15(9):1298–1306. doi:10.1093/ndt/15.9.1298
52. Chen S, Wang H, Lu X, Liu DP, Chen J et al (2010) Polymorphisms in the GNB3 and ADD1 genes and blood pressure in a Chinese population. Hum Genet 128(2):137–143. doi:10.1007/s00439-010-0834-3
53. Yamagishi K, Tanigawa T, Cui R, Tabata M, Ikeda A, Yao M, Shimamoto T, Iso H (2006) G-protein beta-3 subunit C825T polymorphism, sodium and arterial blood pressure: a community-based study of Japanese men and women. Ann Hum Genet 70(Pt 6):759–766. doi:10.1111/j.1469-1809.2006.00276.x
54. Palacios C, Wigertz K, Martin BR, Jackman L, Pratt JH, Peacock M, McCabe G, Weaver CM (2004) Sodium retention in black and white female adolescents in response to salt intake. J Clin Endocrinol Metab 89(4):1858–1863. doi:10.1210/jc.2003-031446
55. The Korean Nutrition Society (2010) Dietary reference intakes for Koreans: first revision 2010. The Korean Nutrition Society, Seoul
56. Naj AC, Jun G, Beecham GW, Wang L-S, Vardarajan BN et al (2011) Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease. Nat Genet 43(5):436–441. doi:10.1038/ng.801
57. Stanger O (2002) Physiology of folic acid in health and disease. Curr Drug Metab 3(2):211–223
58. Alvares Delfino VD, de Andrade Vianna AC, Mocelin AJ, Barbosa DS, Mise RA, Matsuo T (2007) Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients. Nutrition 23(3):242–247. doi:10.1016/j.nut.2007.01.002
59. McEneny J, Couston C, McKibben B, Young IS, Woodside JV (2007) Folate: in vitro and in vivo effects on VLDL and LDL oxidation. Int J Vitam Nutr Res 77(1):66–72
60. Brinkley TE, Nicklas BJ, Kanaya AM, Satterfield S, Lakatta EG, Simonsick EM, Sutton-Tyrrell K, Kritchevsky SB (2009) Plasma oxidized low-density lipoprotein levels and arterial stiffness in older adults: the health, aging, and body composition study. Hypertension 53(5):846–852. doi:10.1161/HYPERTENSIONAHA.108.127043
61. Rojas-Rivera J, Ortiz A, Egido J (2012) Antioxidants in kidney diseases: the impact of bardoxolone methyl. Int J Nephrol 2012:1–11
62. Libby P, Aikawa M (2002) Vitamin C, collagen, and cracks in the plaque. Circulation 105(12):1396–1398
63. Bazzano LA (2011) No effect of folic acid supplementation on cardiovascular events, cancer or mortality after 5 years in people at increased cardiovascular risk, although homocysteine levels are reduced. Evid Based Med 16(4):117–118. doi:10.1136/ebm1204
64. Villacorta L, Graca-Souza AV, Ricciarelli R, Zingg JM, Azzi A (2003) Alpha-tocopherol induces expression of connective tissue growth factor and antagonizes tumor necrosis factor-alpha-mediated downregulation in human smooth muscle cells. Circ Res 92(1):104–110
65. Waters DD, Alderman EL, Hsia J, Howard BV, Cobb FR et al (2002) Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA 288(19):2432–2440